Analyst firms · Raymond James · NVTA

Raymond James NVTA price target and rating history

Invitae Corporation (NVTA) · Health Care

Raymond James rates Invitae Corporation (NVTA) Underperform with a $15 price target, as of its latest action on May 15, 2023. It has published 4 rating actions on NVTA since November 2021, including 0 upgrades and 2 downgrades.

Current rating
Underperform
Price target
$15
Median target, all firms
Too few
Actions on NVTA
4

Raymond James price target on NVTA

$36$26$1520222023202420252026
Raymond James price target on NVTA, each point a stated target, November 2021 to February 2022.

Every Raymond James rating on NVTA

Questions about Raymond James and NVTA

What is Raymond James's price target for NVTA?
Raymond James's latest stated price target for Invitae Corporation (NVTA) is $15, from its action on Feb 28, 2022.
What is Raymond James's rating on NVTA?
Raymond James rates NVTA Underperform, a bearish rating, as of May 15, 2023.
When did Raymond James last change its view on NVTA?
On May 15, 2023, Raymond James downgrades to Underperform from Mkt Perform.

More NVTA rating histories

All Raymond James ratingsNVTA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.